CD22 and non-Hodgkin lymphoma: DCDT2980S is a humanized anti-CD22 antibody linked to the potent monomethyl auristatin E (MMAE) cytotoxic agent via a protease-cleavable linker, and is capable of inducing complete tumor regression in xenograft models of NHL (56).